0MU44KZ
Supplement Elbow Bursa and Ligament, Left to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | M Bursae and Ligaments |
| Operation | U Supplement |
| Body Part | 4 Elbow Bursa and Ligament, Left |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment a bursa or, much more commonly, a ligament that remains largely intact but needs additional structural support. A typical example is augmenting a partially torn ligament with a collagen patch, mesh, or allograft strip to bolster its strength without removing and fully replacing the native tissue.
This approach is chosen when a ligament has enough healthy tissue to preserve but is not strong enough on its own to withstand normal joint stress, often in cases of chronic laxity, partial tearing, or degenerative thinning. It is also used in some reconstructive techniques that combine native ligament preservation with graft augmentation, an increasingly common alternative to full replacement for certain knee and ankle ligament injuries. The added material integrates with the existing structure over time, aiming to restore joint stability while keeping as much of the patient's own tissue as possible.
Anatomy & Axis Detail
Elbow Bursa and Ligament, Left
On the left elbow, the ligament complex, particularly the ulnar collateral ligament along the medial joint line, is the structure most often addressed with a Supplement procedure when chronic valgus stress has caused laxity without complete disruption. Rather than excising the ligament and substituting new tissue entirely, the surgeon reinforces the native band with graft material to restore its tensile strength, a distinction that keeps the procedure classified as Supplement rather than Replacement. The olecranon bursa, which sits superficial to the ligamentous structures and can become chronically inflamed or thinned from repetitive pressure, may also be built up if the record specifies augmentation of its lining. Coders should verify left-sided laterality and confirm the graft material used.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders assign Supplement when the operative note describes reinforcing an existing bursa or ligament with graft, mesh, or other material while the native structure is left in place, not excised. Key language includes "augmented," "reinforced," or "buttressed with graft." The most frequent error is confusing this with Replacement - if the surgeon documents that the damaged ligament was removed before the new material was placed, Replacement is correct instead. Coders should also confirm the supplementing material is a recognized device or biologic value, since the device character of the procedure affects code selection.